MedTrace Logo

TIMING of Oral Anticoagulant Therapy in Acute Ischemic Stroke With Atrial Fibrillation

NCT02961348 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 888

Last updated 2024-05-16

No results posted yet for this study

Summary

This study will compare early with late start of treatment with Non-vitamin K oral anticoagulation (NOAC) in adult patients with acute ischemic stroke and atrial fibrillation; it is a registry-based randomized clinical trial (R-RCT) using The Swedish Stroke Register (Riksstroke). Half of the patients will start NOAC early (within 4 days after stroke onset) while the other half will start late (5-10 days after stroke onset).

Conditions

Interventions

OTHER

Early start of NOAC

Initiation of NOAC up until day 4 after acute ischemic stroke in patients with atrial fibrillation

OTHER

Late start of NOAC

Initiation of NOAC between day 5 and day 10 after acute ischemic stroke in patients with atrial fibrillation

Sponsors & Collaborators

  • The Swedish Stroke Register (Riksstroke)

    collaborator UNKNOWN

  • Uppsala University

    lead OTHER

Principal Investigators

  • Jonas Oldgren, MD. PhD · Dept of Medical Sciences, Uppsala University, Sweden

  • Signild Åsberg, MD. PhD · Dept of Medical Sciences, Uppsala University, Sweden

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-02-15
Primary Completion
2021-06-10
Completion
2024-04-30

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02961348 on ClinicalTrials.gov